⌘K

Login Start Free

Home/Filings/4/0001209191-06-037279

4//SEC Filing

NOVEN PHARMACEUTICALS INC 4

Accession 0001209191-06-037279

CIK 0000815838operating

View on SEC.gov Company Profile

Filed

Jun 18, 8:00 PM ET

Accepted

Jun 19, 5:33 PM ET

Size

7.4 KB

Accession

0001209191-06-037279

Insider Transaction Report

Form 4

Period: 2006-06-16

NOVEN PHARMACEUTICALS INCNOVN

STRAUSS ROBERT C

DirectorPresident, CEO & Chairman

Transactions

Exercise/Conversion
Stock Option (Right to Buy)
2006-06-16−4,588→ 57,912 total
Exercise: $12.94Exp: 2006-11-30→ Common Stock ($ .0001 par value) (4,588 underlying)
Exercise/Conversion
Common Stock ($ .0001 par value)
2006-06-16$12.94/sh+4,588$59,357→ 175,937 total

Footnotes (1)

[F1]10% exercisable after 11/30/2000; 20% exercisable after 11/30/2001; 20% exercisable after 11/30/2002; 25% exercisable after 11/30/2003; 25% exercisable after 11/30/2004.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

NOVEN PHARMACEUTICALS INC

CIK 0000815838

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000815838

Filing Metadata

Form type: 4
Filed: Jun 18, 8:00 PM ET
Accepted: Jun 19, 5:33 PM ET
Size: 7.4 KB

View on SEC.gov